| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Is a Paracrine Inducer of FGF7, a Key Epithelial Growth Factor in Benign Prostatic Hyperplasia
From the Department of Pathology, Baylor College of Medicine; and the Houston Department of Veterans Affairs Medical Center, Houston, Texas
Benign prostatic hyperplasia (BPH) is an extremely common disease
of older men in which there is benign overgrowth of the prostatic
transition zone, leading to obstruction of urine outflow.
FGF7, a potent growth factor for prostatic epithelial
cells, is increased by threefold in BPH and is correlated with
increased epithelial proliferation in this condition.
Immunohistochemistry of normal and hyperplastic prostate revealed that
FGF7-expressing fibroblastic cells were present in higher numbers near
the epithelial acini, implying that epithelial cells may
express a factor that induces FGF7 expression by stromal cells.
Conditioned medium (CM) from primary cultures of prostatic epithelial
cells was capable of inducing a two- to sixfold increase in the
expression of FGF7 by primary stromal cultures. Blocking experiments
with neutralizing anti-interleukin-1
(Il-1
) antibodies and
IL-1Ra, an Il-1
receptor antagonist, show that this
inducing activity was due to the presence of Il-1
in the epithelial
CM. Analysis of normal prostatic peripheral zone and BPH tissue by
enzyme-linked immunoabsorption assay reveal that Il-1
is present at
increased levels in hyperplastic prostate and that levels of Il-1
correlate strongly with tissue FGF7 concentration in BPH. Therefore
Il-1
is produced by prostatic epithelial cells and can induce
FGF7, a potent epithelial growth factor, which can in
turn lead to further epithelial growth and increased Il-1
secretion, thus establishing a double paracrine loop that is
functionally equivalent to an autocrine growth loop. This double
paracrine loop may play a key role in the abnormal proliferation of the
transition zone, which is critical to the pathogenesis of
BPH.
This article has been cited by other articles:
![]() |
I. Kogan-Sakin, M. Cohen, N. Paland, S. Madar, H. Solomon, A. Molchadsky, R. Brosh, Y. Buganim, N. Goldfinger, H. Klocker, et al. Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1 Carcinogenesis, April 1, 2009; 30(4): 698 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Penna, B. Fibbi, S. Amuchastegui, C. Cossetti, F. Aquilano, G. Laverny, M. Gacci, C. Crescioli, M. Maggi, and L. Adorini Human Benign Prostatic Hyperplasia Stromal Cells As Inducers and Targets of Chronic Immuno-Mediated Inflammation J. Immunol., April 1, 2009; 182(7): 4056 - 4064. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Cotton, M. K. O'Bryan, and B. T. Hinton Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction Endocr. Rev., April 1, 2008; 29(2): 193 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Kwabi-Addo, M Ozen, and M Ittmann The role of fibroblast growth factors and their receptors in prostate cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 709 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Giri and M. Ittmann Interleukin-8 Is a Paracrine Inducer of Fibroblast Growth Factor 2, a Stromal and Epithelial Growth Factor in Benign Prostatic Hyperplasia Am. J. Pathol., July 1, 2001; 159(1): 139 - 147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |